Feature | October 30, 2008| Nick Obradovich

Noninvasive Angiography Outlook for 2009

As data accumulates, CTA inches toward gold standard for multiple patient populations.

Toshibas Aquilion 64-slice was used in the Core 64 trial, which showed that coronary CTA was accurate in detecting blockages of greater than 50 percent, with a sensitivity of 85 percent and a specificity of 90 percent.

Going into 2009, proponents of coronary CT angiography (CTA) are confident that the scan’s ever-increasing acceptance will lead to it becoming the gold standard in imaging for patients with low or intermediate risk of coronary artery disease. From a business perspective, the CTA remains a driving force in the cardiac CT market.

While coronary MR angiography (MRA) has seen an improvement in image quality, according to clinicians, the scan is not as accepted or used as much as CTA due to image quality.

Inside the Numbers

CTA scans have increased substantially in the past five years, according to many clinicians. In March 2008, IMV Medical Information Division Inc., a market research firm specializing in medical imaging, released a study confirming the data.
According to IMV’s report, there were approximately 4.7 million CTA scans performed in 2007, increasing from 2.2 million scans in 2003. The report found that among sites with CT scanners, 66 percent performed CTA scans in 2007. In 2003, under half (44 percent) of sites with CT scanners performed CTA.

According to a June IMV report, there were approximately 2.5 million MRA scans. Taking the total number of CTA and MRA scans for 2007 (7.2 million), nearly two-thirds were CTA, underscoring the fact that CTA has leaped ahead of MRA.

CTA appears to enjoy the advantage over MRA when imaging the coronary arteries, primarily due to superior spatial resolution. Some clinicians believe that an coronary MRA can be read as effectively as a CTA scan if the cardiologist or radiologist has experience reading both scans.

Core 64 Results

Not all cardiologists believe CTA should be the gold standard for finding and accessing blocked arteries, but last year’s results of the Coronary Artery Evaluation Using 64-Row Multidetector Computed Tomography Angiography trial (CORE-64) trial leant statistical credibility to the scan. The CORE-64 trial — funded by Toshiba America Medical Systems — was conducted by researchers from nine centers in seven countries. The trial studied 291 patients who were scheduled to undergo invasive coronary angiography for suspected or unknown coronary artery disease.

Using Toshiba’s Aquilion 64 CT scanner, the trial found that CTA was accurate in detecting blockages of greater than 50 percent, with a sensitivity of 85 percent and a specificity of 90 percent.

“I was always thought that, even with the 16-row Aquilion we had, MDCTA for the coronary arteries was ready for prime time,” said Melvin E. Clouse, M.D., radiologist at Beth Israel Deaconess Medical Center, professor and vice chairman emeritus, department of radiology, Harvard Medical School. “The first image I ever took with it was one of the best I had ever done. Even if you believed [that 64-slice CTA was an effective scan], I think Core 64 proved it.”

Many clinicians feel the urgency of developing a cardiac test that can better determine who is valuable to having a heart attack.

“For about 200,000 people every year, a fatal heart attack is their first, last and only symptom,” Dr. Clouse said. “So what you want to do is get a simple test.”

Going into 2009, clinicians are optimistic about CTA’s future, in large part to due technological innovations. Siemens’ SOMATOM Definition with dual-source technology has improved temporal resolution and helps better characterize plaque, according to several clinicians who have spoken to Diagnostic & Invasive Cardiology this year. Toshiba’s Aquilion One 320-slice required less contrast, reducing the dose to levels near what would be used in a cath lab, according to clinicians.

“Our goal should be to reduce the number of imaging methods for the heart, if that can be done,” Dr. Clouse said. “MDCT is much more rapid, less complicated, and eventually, I think, we’ll get to perfusion imaging. We’ll be competing actively with MRI. But, we have to do it without so much radiation. We should target our studies where we get our dose rates down to 3 and 5 milliseverts for an angio study.”

Related Content

HeartFlow, FFR-CT Analysis, next-generation platform, second FDA clearance
Technology | CT Angiography (CTA)| June 29, 2016
HeartFlow Inc. announced that it is launching its next generation of the HeartFlow FFR-CT Analysis. The result of years...
DEFUSE-2 study, MRI, brain bleeding risk, post-stroke treatment, NIH

This image combines pre- and post-treatment scans from the same patient. Analysis of the two scans revealed that the area and size of post-treatment bleeding corresponded to blood-brain barrier disruption (shown in green, yellow and red) prior to therapy. Image courtesy of Richard Leigh, NINDS.

News | Stroke| June 29, 2016
In a study of stroke patients, investigators confirmed through magnetic resonance imaging (MRI) brain scans an...
Sponsored Content | Videos | Cardiovascular Ultrasound| June 28, 2016
Interview with Rebecca Hahn, M.D., FASE, Columbia University Medical Center, New York, at the American Society of Ech
CT scans, cancer risk, radiation dose, Canadian study
News | Computed Tomography (CT)| June 27, 2016
June 27, 2016 — A new study in the Journal of Medical Imaging and Radiation Sciences surveyed doctors, radiologists a
BHF, Reflections of Research image competition, U.K., 4-D MRI, heart blood flow

This image shows blood flow within the main pumping chambers – the ventricles – on both sides of the heart and the vessels leaving the heart. The blue flow is blood that needs oxygen and is travelling to the lungs. The red flow is blood that has been through the lungs and received oxygen. Victoria Stoll of the University of Oxford is using this type of imaging to look at the blood flow within the hearts of people with heart failure, whose hearts are not pumping effectively.

News | Cardiac Imaging| June 24, 2016
The British Heart Foundation (BHF) announced the winners of its annual ‘Reflections of Research’ image competition,...
Biotronik, CardioStim 2016 Innovation Award, MRI AutoDetect, Ilivia ICDs
News | EP Lab| June 23, 2016
Biotronik announced it was the winner of the Cardiostim Innovation Award in the category “Best Practice Improvement”...
CAD-RADS, coronary CT angiography, CCTA, reporting, SCCT, ACR, NASCI, ACC

A coronary CTA scan from a Philips CT scanner illustrating a curved multiplaner reconstruction showing a large occlusion of the artery. 

News | CT Angiography (CTA)| June 17, 2016
Three medical professional societies this week jointly released a new reporting system to standardize reporting of...
ZOOM+Imaging, on-demand service, X-ray, ultrasound, CT
News | Business| June 15, 2016
ZOOM+ announced the launch of ZOOM+Imaging, a proprietary digital platform for on-demand scheduling, paying and sharing...
GE Healthcare, Getinge Group, Maquet, Discovery IGS 730 angiography system, Magnus operating table, integrated, hybrid OR

GE Healthcare's Discovery IGS 730 angiography system

Technology | Hybrid OR| June 13, 2016
GE Healthcare and Getinge Group announced the U.S. launch of a new, highly flexible angiography solution for surgery,...
McKesson, iPad, CVIS, ECG mobile viewer

Dynamic ECG waveforms displayed on an iPad using McKesson's mobile ECG viewer, which directly connects to the hospital's cardiovascular information system or ECG management system. This technology can help speed triage of STEMI patients, allowing diagnosis anywhere, rather than requiring cardiologists to walk down to an emergency department or drive into the hospital to view the ECG.

Feature | Mobile Devices| June 09, 2016 | Dave Fornell
The ubiquitous smartphone has found its way into the pockets of nearly every clinician and patient in recent years an
Overlay Init